SC
DGX icon

SouthState Corp’s Quest Diagnostics DGX Stock Holding History

SouthState Corp’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.91K Buy
9
+3
+50% +$589 ﹤0.01% 960
2026
Q1 		$1.18K Sell
6
-13
-68% -$2.53K ﹤0.01% 1012
2025
Q4 		$3.3K Buy
19
+13
+217% +$2.37K ﹤0.01% 881
2025
Q3 		$1.14K Sell
6
-4
-40% -$710 ﹤0.01% 1035
2025
Q2 		$1.8K Sell
10
-1
-9% -$174 ﹤0.01% 1121
2025
Q1 		$1.86K Buy
+11
New +$1.81K ﹤0.01% 1201

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

SouthState Corp's DGX Position: Q2 2026 in Review

SouthState Corp increased its Quest Diagnostics (DGX) stake by 50% in Q2 2026, buying an estimated $589 and bringing the position to 9 shares worth $1.91K. The position accounts for ﹤0.01% of the portfolio, ranked #960.

SouthState Corp first reported a position in DGX in Q1 2025 and has held it in 6 quarters since. The position peaked at $3.3K in Q4 2025. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • SouthState Corp held 9 shares of Quest Diagnostics worth $1.91K as of Q2 2026.
  • SouthState Corp bought 3 Quest Diagnostics shares in Q2 2026, an estimated $589.
  • Quest Diagnostics made up ﹤0.01% of SouthState Corp's portfolio in Q2 2026, its #960 holding.
  • SouthState Corp first reported a position in Quest Diagnostics in Q1 2025 and has held it in 6 quarters since.
  • SouthState Corp's Quest Diagnostics position peaked at $3.3K in Q4 2025.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on SouthState Corp's 13F filing for Q2 2026, filed 6 Aug 2026.